Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (73294) 73294
Publication (8982) 8982
Newsletter (6884) 6884
Newspaper Article (2458) 2458
Book Review (1717) 1717
Book / eBook (973) 973
Book Chapter (708) 708
Conference Proceeding (229) 229
Dissertation (187) 187
Magazine Article (102) 102
Transcript (66) 66
Trade Publication Article (59) 59
Data Set (24) 24
Government Document (10) 10
Paper (9) 9
Reference (9) 9
Web Resource (7) 7
Presentation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (41573) 41573
index medicus (37813) 37813
animals (32200) 32200
vascular endothelial growth factor (30090) 30090
angiogenesis (19453) 19453
male (18494) 18494
female (17572) 17572
research (15412) 15412
mice (14849) 14849
expression (12207) 12207
cancer (11030) 11030
oncology (10402) 10402
proteins (9910) 9910
endothelial growth-factor (9433) 9433
cells, cultured (8909) 8909
medicine (8672) 8672
rats (8494) 8494
gene expression (8424) 8424
cell biology (8394) 8394
research article (8278) 8278
peripheral vascular disease (8269) 8269
middle aged (8140) 8140
rodents (7894) 7894
inflammation (7833) 7833
signal transduction (7580) 7580
physiology (7329) 7329
vascular endothelial growth factor a - metabolism (7297) 7297
health aspects (7263) 7263
care and treatment (7186) 7186
physiological aspects (7118) 7118
endothelium (7046) 7046
adult (6982) 6982
apoptosis (6918) 6918
multidisciplinary sciences (6880) 6880
aged (6414) 6414
kinases (6379) 6379
cells (6377) 6377
cardiac & cardiovascular systems (6321) 6321
atherosclerosis (6179) 6179
vegf (6152) 6152
analysis (6139) 6139
cardiovascular disease (5853) 5853
risk factors (5826) 5826
science (5814) 5814
studies (5806) 5806
metastasis (5474) 5474
tumors (5438) 5438
biochemistry & molecular biology (5367) 5367
medicine, research & experimental (5356) 5356
article (5336) 5336
endothelial cells (5331) 5331
neovascularization (5323) 5323
hypertension (5232) 5232
activation (5078) 5078
cardiovascular system (5060) 5060
hematology (4981) 4981
cardiovascular diseases (4922) 4922
immunohistochemistry (4876) 4876
genetic aspects (4796) 4796
diabetes (4761) 4761
oxidative stress (4701) 4701
biology (4559) 4559
cytokines (4484) 4484
in-vivo (4443) 4443
disease models, animal (4399) 4399
review (4301) 4301
hypoxia (4274) 4274
phosphorylation (4269) 4269
cell proliferation (4206) 4206
endothelial-cells (4179) 4179
development and progression (4114) 4114
endothelium, vascular - metabolism (4085) 4085
mice, inbred c57bl (4064) 4064
receptor (3951) 3951
in-vitro (3914) 3914
medical research (3859) 3859
cell line, tumor (3811) 3811
vascular endothelial growth factor a - genetics (3706) 3706
growth factors (3697) 3697
pharmacology & pharmacy (3688) 3688
disease (3648) 3648
stem cells (3599) 3599
inhibition (3526) 3526
endothelium, vascular - cytology (3503) 3503
gene-expression (3438) 3438
endothelial cells - metabolism (3390) 3390
immunology (3381) 3381
growth-factor (3380) 3380
growth (3322) 3322
endocrinology & metabolism (3292) 3292
rats, sprague-dawley (3215) 3215
heart (3176) 3176
receptors (3148) 3148
proliferation (3075) 3075
biochemistry (3064) 3064
nitric oxide (3033) 3033
reports (2996) 2996
vascular endothelial growth factor a (2986) 2986
ischemia (2983) 2983
patients (2930) 2930
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (730) 730
Collection Dvlpm't (Acquisitions) - Vendor file (42) 42
Collection Dvlpm't (Acquisitions) - Closed Orders (38) 38
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (17) 17
Scarborough Hospital - General (14) 14
St. Michael's Hospital - Stacks (13) 13
Humber River Regional Hospital - Church Stacks (12) 12
Online Resources - Online (12) 12
Providence Healthcare - Stacks (11) 11
Humber River Regional Hospital - Finch Stacks (8) 8
Toronto East General Hospital - Stacks (8) 8
UTL at Downsview - May be requested (8) 8
UofT at Mississauga - Stacks (8) 8
Credit Valley Hospital - Stacks (7) 7
Lakeridge Health Sciences - Oshawa (7) 7
Scarborough Hospital - Birchmount (7) 7
Gerstein Science - Circulation Desk (6) 6
UofT at Scarborough - Stacks (6) 6
West Park Healthcare Centre - Stacks (6) 6
Providence Healthcare - Reference (5) 5
Trillium Health Centre - Stacks (5) 5
Gerstein Science - Missing (4) 4
Markham Stouffville Hospital - Stacks (3) 3
Toronto East General Hospital - Reference (3) 3
Baycrest Hospital - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (2) 2
Humber River Regional Hospital - Stacks (2) 2
Providence Healthcare - Reserve desk (2) 2
Baycrest Hospital - Wellness Library (1) 1
Church Stacks (1) 1
Credit Valley Hospital - Online (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Engineering & Comp. Sci. - May be requested in 6-10 wks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Finch Stacks (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Mt Sinai Hospital - Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
St Josephs Health Centre - Reference (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Lost (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Pharmacy (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
West Park Healthcare Centre - Missing (1) 1
West Park Healthcare Centre - Pharmacy (1) 1
Women's College Hospital - Online (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (84094) 84094
Chinese (197) 197
Japanese (78) 78
German (69) 69
French (59) 59
Spanish (46) 46
Portuguese (38) 38
Russian (37) 37
Polish (33) 33
Korean (29) 29
Turkish (15) 15
Hungarian (9) 9
Czech (5) 5
Latvian (2) 2
Persian (2) 2
Romanian (2) 2
Slovenian (2) 2
Swedish (2) 2
Arabic (1) 1
Bulgarian (1) 1
Dutch (1) 1
Indonesian (1) 1
Italian (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Romansh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): A dual receptor antagonism
by Goyal, Atul and Pal, Nutan and Concannon, Matthew and Paul, Matthew and Doran, Mike and Poluzzi, Chiara and Sekiguchi, Kiyotoshi and Whitelock, John M and Neill, Thomas and Iozzo, Renato V
Journal of Biological Chemistry, ISSN 0021-9258, 07/2011, Volume 286, Issue 29, pp. 25947 - 25962
Endorepellin, the C-terminal module of perlecan, negatively regulates angiogenesis counter to its proangiogenic parental molecule. Endorepellin (the C-terminal... 
Transcription, Genetic - drug effects | Vascular Endothelial Growth Factor A - biosynthesis | Vascular Endothelial Growth Factor Receptor-1 - antagonists & inhibitors | Humans | Angiostatic Proteins - pharmacology | Peptide Fragments - pharmacology | Vascular Endothelial Growth Factor A - genetics | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Vascular Endothelial Growth Factor A - pharmacology | Heparan Sulfate Proteoglycans - chemistry | Protein Structure, Tertiary | Cell Line | Peptide Fragments - metabolism | Endothelial Cells - metabolism | Angiostatic Proteins - chemistry | Rats | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Down-Regulation - drug effects | Vascular Endothelial Growth Factor Receptor-1 - chemistry | Protein Transport | Peptide Fragments - chemistry | Vascular Endothelial Growth Factor Receptor-2 - chemistry | Animals | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - metabolism | Heparan Sulfate Proteoglycans - metabolism | Integrin alpha2beta1 - antagonists & inhibitors | Protein Binding | Integrin alpha2beta1 - metabolism | Angiostatic Proteins - metabolism | Endothelial Cells - drug effects | Heparan Sulfate Proteoglycans - pharmacology | Proteoglycan Structure | VEGFR2 | Basement Membrane | Perlecan | Heparan Sulfate | Glycobiology and Extracellular Matrices | Cell Surface Receptor | α2β1 Integrin | Protein-Protein Interactions | Endorepellin | Heparan Sulfate Proteoglycan
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Galectin-3 protein modulates cell surface expression and activation of vascular endothelial Growth factor receptor 2 in human endothelial cells
by Markowska, Anna I and Jefferies, Kevin C and Panjwani, Noorjahan
Journal of Biological Chemistry, ISSN 0021-9258, 08/2011, Volume 286, Issue 34, pp. 29913 - 29921
Angiogenesis is heavily influenced by VEGF-A and its family of receptors, particularly VEGF receptor 2 (VEGF-R2). Like most cell surface proteins, VEGF-R2 is... 
CORNEAL NEOVASCULARIZATION | ANGIOGENESIS | MEMBRANE | BIOCHEMISTRY & MOLECULAR BIOLOGY | BINDING LECTIN | MICE | GLYCOSYLATION | VEGF-A | CARCINOMA | CANCER | Endothelial Cells - metabolism | Humans | Cells, Cultured | Galectin 3 - metabolism | Gene Expression Regulation - physiology | N-Acetylglucosaminyltransferases - genetics | Cell Membrane - genetics | Corneal Neovascularization - genetics | Vascular Endothelial Growth Factor A - metabolism | Galectin 3 - genetics | Vascular Endothelial Growth Factor A - genetics | N-Acetylglucosaminyltransferases - metabolism | Mice, Knockout | Vascular Endothelial Growth Factor Receptor-2 - genetics | Animals | Corneal Neovascularization - metabolism | Endothelial Cells - cytology | Signal Transduction - physiology | Vascular Endothelial Growth Factor Receptor-2 - biosynthesis | Cell Membrane - metabolism | Mice | Enzyme Activation - physiology | VEGF-R2 | Angiogenesis | Cell Surface Protein | Mgat5 | VEGF | Glycoprotein | Glycobiology and Extracellular Matrices | Receptor Endocytosis | Galectin-3 | Carbohydrate Binding Protein | Protein Cross-linking
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Vascular endothelial growth factor receptor-2 in breast cancer
by Guo, Shanchun and Colbert, Laronna S and Fuller, Miles and Zhang, Yuanyuan and Gonzalez-Perez, Ruben R
BBA - Reviews on Cancer, ISSN 0304-419X, 2010, Volume 1806, Issue 1, pp. 108 - 121
Investigations over the last decade have established the essential role of growth factors and their receptors during angiogenesis and carcinogenesis. The... 
Tumor angiogenesis | Autocrine/paracrine loop | Breast cancer | VEGF | VEGFR-2 | Leptin | BIOCHEMISTRY & MOLECULAR BIOLOGY | VEGF RECEPTOR-2 | NECROSIS-FACTOR-ALPHA | CELL LUNG-CANCER | PHASE-III TRIAL | SIGNAL-TRANSDUCTION | DOMAIN-CONTAINING RECEPTOR | BIOPHYSICS | ONCOLOGY | IN-VIVO | TYROSINE KINASE INHIBITOR | NF-KAPPA-B | Promoter Regions, Genetic | Signal Transduction | Cell Survival | Epigenesis, Genetic | Humans | Breast Neoplasms - etiology | Breast Neoplasms - drug therapy | Vascular Endothelial Growth Factor Receptor-2 - genetics | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-2 - chemistry | Angiogenesis Inhibitors - therapeutic use | Female | Vascular Endothelial Growth Factor Receptor-2 - physiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents
by Falcon, Beverly L and Chintharlapalli, Sudhakar and Uhlik, Mark T and Pytowski, Bronislaw
Pharmacology and Therapeutics, ISSN 0163-7258, 08/2016, Volume 164, pp. 204 - 225
Interaction of numerous signaling pathways in endothelial and mesangial cells results in exquisite control of the process of physiological angiogenesis, with a... 
Angiogenesis | Endothelial cell | Ramucirumab | VEGFR-2 | DC101 | Tumor vasculature | ADVANCED HEPATOCELLULAR-CARCINOMA | HUMAN TUMOR XENOGRAFTS | PANCREATIC NEUROENDOCRINE TUMORS | HUMAN MONOCLONAL-ANTIBODY | PROGENITOR-CELL MOBILIZATION | BEVACIZUMAB PLUS IRINOTECAN | METASTATIC COLORECTAL-CANCER | COMBINATION METRONOMIC CHEMOTHERAPY | PHARMACOLOGY & PHARMACY | SOFT-TISSUE SARCOMA | HYPOXIA-INDUCIBLE FACTOR-1 | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Animals | Neovascularization, Pathologic - drug therapy | Antibodies, Monoclonal - pharmacology | Humans | Neovascularization, Pathologic - physiopathology | Neoplasms - physiopathology | Drug Therapy, Combination | Drug Resistance, Neoplasm - physiology | Neoplasms - drug therapy | Antimitotic agents | Lung cancer | Physiological aspects | Monoclonal antibodies | Neovascularization | Antineoplastic agents | Vascular endothelial growth factor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression
by Facemire, Carie S and Nixon, Andrew B and Griffiths, Robert and Hurwitz, Herbert and Coffman, Thomas M
Hypertension, ISSN 0194-911X, 09/2009, Volume 54, Issue 3, pp. 652 - 658
Drugs and antibodies that interrupt vascular endothelial growth factor (VEGF) signaling pathways improve outcomes in patients with a variety of cancers by... 
Hypertension | Angiogenesis | Vascular endothelial growth factor | Cancer | TYROSINE KINASE-1 | angiogenesis | vascular endothelial growth factor | VEGF | MOUSE | PERIPHERAL VASCULAR DISEASE | cancer | MONOCLONAL-ANTIBODY | MICE | PREECLAMPSIA | hypertension | MOLECULAR-MECHANISMS | Gene Expression - drug effects | Kidney - enzymology | Antibodies, Monoclonal - adverse effects | Sodium Chloride, Dietary - administration & dosage | Male | Vascular Endothelial Growth Factor Receptor-2 - immunology | RNA, Messenger - metabolism | Aldosterone - urine | Hypertension - etiology | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Renin - genetics | Prostaglandins - urine | Nitric Oxide Synthase Type I - antagonists & inhibitors | Blood Pressure - drug effects | Blood Pressure - physiology | Vascular Endothelial Growth Factor Receptor-2 - physiology | Nitric Oxide Synthase Type III - metabolism | Manometry | NG-Nitroarginine Methyl Ester - pharmacology | Nitric Oxide - biosynthesis | Kidney - drug effects | Antibodies, Monoclonal - pharmacology | RNA, Messenger - genetics | Sodium Chloride, Dietary - adverse effects | Enzyme Inhibitors - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Nitric Oxide Synthase Type III - genetics | Hypertension - physiopathology | Nitric Oxide Synthase Type III - antagonists & inhibitors | Animals | Signal Transduction - drug effects | Nitric Oxide Synthase Type I - metabolism | Hybridomas | Mice | Nitric Oxide Synthase Type I - genetics | Vascular Endothelial Growth Factor A - physiology | Index Medicus | nitric oxide
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling
by Yi, Tingfang and Yi, Zhengfang and Cho, Sung-Gook and Luo, Jian and Pandey, Manoj K and Aggarwal, Bharat B and Liu, Mingyao
Cancer Research, ISSN 0008-5472, 03/2008, Volume 68, Issue 6, pp. 1843 - 1850
Gambogic acid (GA), the main active compound of Gamboge hanburyi, has been previously reported to activate apoptosis in many types of cancer cell lines by... 
APOPTOSIS | IN-VITRO | TRANSFERRIN RECEPTOR | ONCOLOGY | PHOSPHORYLATION | VEGF | HEPATOMA SMMC-7721 CELLS | TYROSINE KINASES | FOCAL ADHESION KINASE | CANCER | DISCOVERY | Prostatic Neoplasms - blood supply | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Apoptosis - drug effects | Cell Growth Processes - drug effects | Humans | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Male | Mice, SCID | Xanthones - pharmacology | Neovascularization, Pathologic - pathology | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Animals | Signal Transduction - drug effects | Endothelial Cells - cytology | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Mice | Neovascularization, Pathologic - metabolism | Prostatic Neoplasms - drug therapy | Endothelial Cells - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2
by Eder, Joseph Paul and Shapiro, Geoffrey I and Appleman, Leonard J and Zhu, Andrew X and Miles, Dale and Keer, Harold and Cancilla, Belinda and Chu, Felix and Hitchcock-Bryan, Suzanne and Sherman, Laurie and McCallum, Stewart and Heath, Elisabeth I and Boerner, Scott A and LoRusso, Patricia M
Clinical Cancer Research, ISSN 1078-0432, 07/2010, Volume 16, Issue 13, pp. 3507 - 3516
Purpose: Foretinib is an oral multikinase inhibitor targeting Met, RON, Axl, and vascular endothelial growth factor receptor. We conducted a phase I,... 
TARGET | ANGIOGENESIS | ONCOLOGY | OPINION | HEPATOCYTE | EXPRESSION | CANCER | Anilides - therapeutic use | Drug Administration Schedule | Administration, Oral | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Neoplasms - drug therapy | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Maximum Tolerated Dose | Neoplasm Metastasis | Antineoplastic Agents - adverse effects | Protein Kinase Inhibitors - therapeutic use | Adult | Female | Aged | Quinolines - therapeutic use | Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Downregulation of Endothelial MicroRNA-200b Supports Cutaneous Wound Angiogenesis By Desilencing GATA Binding Protein 2 and Vascular Endothelial Growth Factor Receptor 2
by Chan, Yuk Cheung and Roy, Sashwati and Khanna, Savita and Sen, Chandan K
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 06/2012, Volume 32, Issue 6, pp. 1372 - 1382
OBJECTIVE—MicroRNAs (miRs) regulate angiogenesis by posttranscriptional silencing of target genes. The significance of angiostatic miR-200b in switching on... 
Angiogenesis | Wound healing | GATA binding protein 2 | Vascular endothelial growth factor receptor 2 | MicroRNAs | microRNAs | CELLS | wound healing | vascular endothelial growth factor receptor 2 | angiogenesis | CANCER | P53 | INFLAMMATION | IN-VIVO | PERIPHERAL VASCULAR DISEASE | MICE | GENE-TRANSFER | SKIN | HEMATOLOGY | EXPRESSION | Diabetes Mellitus - pathology | Tumor Necrosis Factor-alpha - metabolism | Genetic Therapy | Receptors, Leptin - genetics | Diabetes Mellitus - genetics | Skin - metabolism | Wounds, Penetrating - therapy | Humans | Receptors, Tumor Necrosis Factor, Type I - administration & dosage | Male | MicroRNAs - metabolism | Wound Healing | RNA, Messenger - metabolism | Skin - injuries | Vascular Endothelial Growth Factor Receptor-2 - genetics | Transfection | RNA Interference | Time Factors | Wounds, Penetrating - genetics | HEK293 Cells | Lentivirus - genetics | GATA2 Transcription Factor - genetics | Genes, Reporter | Skin - pathology | Disease Models, Animal | Injections, Intradermal | Signal Transduction | Endothelial Cells - metabolism | Down-Regulation | Mice, Inbred C57BL | Diabetes Mellitus - metabolism | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Laser-Doppler Flowmetry | Regional Blood Flow | Blotting, Western | Skin - blood supply | Animals | Diabetes Mellitus - therapy | GATA2 Transcription Factor - metabolism | Wounds, Penetrating - pathology | Mice | Mutation | Receptors, Leptin - metabolism | Genetic Vectors | Wounds, Penetrating - metabolism | Neovascularization, Physiologic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti‐tumour effect in vivo
by Yasuda, S and Sho, M and Yamato, I and Yoshiji, H and Wakatsuki, K and Nishiwada, S and Yagita, H and Nakajima, Y
Clinical & Experimental Immunology, ISSN 0009-9104, 06/2013, Volume 172, Issue 3, pp. 500 - 506
Recent basic and clinical studies have shown that the programmed death ligand ( PD ‐ L) / PD ‐1 pathway has a significant role in tumour immunity, and its... 
VEGFR | anti‐angiogenesis | immune checkpoint | anti‐tumour immunity | VEGFR2 | Anti-tumour immunity | Immune checkpoint | Anti-angiogenesis | PD-1 | IMMUNITY | ANGIOGENESIS | TUMOR | ANTIBODY | IMMUNOLOGY | HUMAN PANCREATIC-CANCER | THERAPY | IMMUNOTHERAPY | anti-angiogenesis | anti-tumour immunity | EXPRESSION | CLINICAL-SIGNIFICANCE | Colonic Neoplasms - therapy | Colonic Neoplasms - blood supply | Adenocarcinoma - immunology | Humans | Neoplasms, Experimental - therapy | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-2 - immunology | Adenocarcinoma - blood supply | Drug Synergism | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Angiogenesis Inhibitors - administration & dosage | Animals | Adenocarcinoma - therapy | Antibodies, Monoclonal - administration & dosage | Colonic Neoplasms - immunology | Neoplasms, Experimental - immunology | Cell Line, Tumor | Female | Neovascularization, Pathologic - prevention & control | Mice | Mice, Inbred BALB C | Programmed Cell Death 1 Receptor - immunology | Lymphocytes, Tumor-Infiltrating - immunology | Neoplasms, Experimental - blood supply | Monoclonal antibodies | Neovascularization | Endothelial growth factors | Tumors | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights